OncoPharm cover image

Lirafugratinib + LITESPARK011

OncoPharm

00:00

FGFR Inhibitor Hyperphosphatemia And Eye Toxicity

John Bazar compares hyperphosphatemia and retinal pigment epithelial detachment rates, highlighting reduced phosphate toxicity but potentially greater ocular toxicity with lirafugratinib.

Play episode from 01:47
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app